Catalyst Wire Dossier Catalyst Wire Dossier

LIVMARLI

Maralixibat chloride · Mirum Pharmaceuticals Inc.
Drug timelines are a Plus or Pro feature.

11 regulatory and trial events tracked for LIVMARLI, covering 2021-09-29 to 2026-04-17. Get the full timeline:

Most recent: EMA Authorised: Livmarli (Maralixibat chloride) — Mirum Pharmaceuticals International B.V.

See pricing